Robert E. Donahue

What is he best known for?

The fields of study he is best known for:

• Gene
• Immune system
• Internal medicine

Robert E. Donahue mainly focuses on Stem cell, Molecular biology, Progenitor cell, Haematopoiesis and Immunology. His study ties his expertise on Bone marrow together with the subject of Stem cell. His research in Bone marrow intersects with topics in Virus and Virology.

The concepts of his Molecular biology study are interwoven with issues in Ex vivo, Stem cell factor and Gene, Transduction. His Haematopoiesis research incorporates elements of Myeloid, Genetically modified organism and Green fluorescent protein. His Immunology study combines topics from a wide range of disciplines, such as Factor IX, Transgene and Transplantation.

His most cited work include:

• Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. (496 citations)
• High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes (247 citations)
• Ex Vivo Expansion of Genetically Marked Rhesus Peripheral Blood Progenitor Cells Results in Diminished Long-Term Repopulating Ability (239 citations)

What are the main themes of his work throughout his whole career to date?

Robert E. Donahue mainly focuses on Haematopoiesis, Stem cell, Immunology, Transplantation and CD34. His work deals with themes such as Progenitor cell, Genetic enhancement, Transduction and Virology, which intersect with Haematopoiesis. His research integrates issues of Viral vector, Transgene and In vivo in his study of Virology.

Robert E. Donahue interconnects Molecular biology, Cancer research and Bone marrow in the investigation of issues within Stem cell. As a member of one scientific family, Robert E. Donahue mostly works in the field of Immunology, focusing on Leukapheresis and, on occasion, Immunophenotyping. His study in Transplantation is interdisciplinary in nature, drawing from both Spleen, Andrology, Gene, Globin and Leukemia.

He most often published in these fields:

• Haematopoiesis (51.27%)
• Stem cell (46.20%)
• Immunology (42.41%)

What were the highlights of his more recent work (between 2017-2021)?

• Haematopoiesis (51.27%)
• Transplantation (38.61%)
• Stem cell (46.20%)

In recent papers he was focusing on the following fields of study:

His main research concerns Haematopoiesis, Transplantation, Stem cell, Progenitor cell and Genetic enhancement. His Haematopoiesis study frequently links to other fields, such as CD34. His Transplantation research integrates issues from Genome editing and Gene, Globin.

He has researched Stem cell in several fields, including Cancer research and Bone marrow. His Progenitor cell study combines topics in areas such as Myeloid, T cell and Enhancer. His Genetic enhancement research includes themes of Erythropoietin, Hematopoietic stem cell, Autologous transplantation and Viral vector.

Between 2017 and 2021, his most popular works were:

• Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia (141 citations)
• Geographic clonal tracking in macaques provides insights into HSPC migration and differentiation. (25 citations)
• The impact of aging on primate hematopoiesis as interrogated by clonal tracking. (19 citations)

In his most recent research, the most cited papers focused on:

• Gene
• Immune system
• Internal medicine

The scientist’s investigation covers issues in Haematopoiesis, Progenitor cell, Stem cell, Genetic enhancement and Cell biology. His studies examine the connections between Haematopoiesis and genetics, as well as such issues in Transplantation, with regards to Bone marrow. His Bone marrow study integrates concerns from other disciplines, such as Enhancer, Molecular biology and Erythropoiesis, GATA1.

His Progenitor cell study deals with Myeloid intersecting with Stem cell factor, Clone, Myeloid leukemia, Leukemia and CD33. The Stem cell study combines topics in areas such as Lineage, Immunotherapy, Immunology and Primate. His Genetic enhancement research incorporates elements of Hematopoietic stem cell, Viral vector, Transduction and Cancer research.